The potential for hydroxychloroquine to interact with vaccines, particularly in autoimmune patients, underscores the importance of understanding its effects on immune responses to vaccination. Research into the timing and administration of vaccines in conjunction with
hydroxychloroquine for lupus therapy could optimize vaccine efficacy and safety for these vulnerable populations.
